Back

Testosterone and atrial fibrillation: does the dose make the poison?

Cardiovascular Research

21 June 2025
Organised by: Logo
Read full article
ESC Journals BASIC SCIENCE

Contributors

Fleur E Mason
Fleur E Mason

Author

Aiste Liutkute
Aiste Liutkute

Author

Niels Voigt
Niels Voigt

Author

Institute of Pharmacology and Toxicology, University Medical Center Goettingen Goettingen , Germany

You may be interested in
thumbnail
Congress Presentation
Association of serum testosterone levels with left atrial size, function, and risk of atrial fibrillation in adult men: observational and mendelian randomization analyses
2 September 2024
thumbnail
Congress Presentation
One-year outcomes of inappropriate DOAC dosing in patients with atrial fibrillation
21 March 2026
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
17 May 2025
thumbnail
Congress Presentation
Sex differences in the use of rhythm control strategies in patients with atrial fibrillation in FinACAF study
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources